CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Identification of a novel orally bioavailable ERK5 inhibitor with selectivity over p38α and BRD4
Authors
Arasta M
Bawn RH
+28 more
Blackburn TJ
Cano C
Cook SJ
Edwards N
Endicott JA
Golding BT
Griffin RJ
Hammonds T
Hardcastle IR
Harnor SJ
Heptinstall AB
Lochhead PA
Martin MP
Martin NC
Miller DC
Molyneux L
Myers SM
Newell DR
Noble MEM
Owen PJ
Pang LC
Reuillon T
Rigoreau LJM
Thomas HD
Tucker JA
Wang L-Z
Wedge SR
Wong A-C
Publication date
15 September 2019
Publisher
Elsevier Masson SAS
Abstract
Abstract is not available.
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Newcastle University E-Prints
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:eprints.ncl.ac.uk:258337
Last time updated on 30/05/2021